New Drug Makes it Easier for the Immune System to Kill Cancer Cells
In addition to enabling the immune system to attack, the drug directly targets lung cancer cells.
Advertisement
A new mRNA therapy represents an important step towards a potential curative treatment for heart disease.
Ritual supplements are designed with delayed-release technology, helping nutrients reach the small intestine effectively.
Ritual founder and CEO Kat Schneider joins Tomorrow’s World Today to break down some of the decisions that helped shape the company’s identity, from its name and packaging to the customer experience surrounding the products.